Lazard Asset Management LLC Biogen Inc. Transaction History

Lazard Asset Management LLC

$72.9 Billion
Q2 2024

A detailed history of Lazard Asset Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 20,136 shares of BIIB stock, worth $3.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

20,136

Previous 22,719 11.37%

Holding current value

$3.5 Million

Previous $4.9 Million 4.72%

% of portfolio

0.01%

Previous 0.01%

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $492,113 - $611,447	-2,583 Reduced 11.37%	20,136 $4.67 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $512,452 - $647,055	-2,417 Reduced 9.62%	22,719 $4.9 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $154,032 - $185,414	-692 Reduced 2.68%	25,136 $6.5 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $2.8 Million - $3.16 Million	11,066 Added 74.96%	25,828 $6.64 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $178,086 - $205,784	-647 Reduced 4.2%	14,762 $4.2 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $57,726 - $65,776	-225 Reduced 1.44%	15,409 $4.28 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $393,301 - $477,869	1,558 Added 11.07%	15,634 $4.33 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $2.48 Million - $3.42 Million	12,742 Added 955.17%	14,076 $3.76 Million
Q2 2022 Aug 09, 2022	BUY	$187.54 - $223.02 $99,771 - $118,646	532 Added 66.33%	1,334 $271,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $737,876 - $929,685	-3,808 Reduced 82.6%	802 $168,000
Q4 2021 Feb 09, 2022	BUY	$223.92 - $287.77 $67,176 - $86,331	300 Added 6.96%	4,610 $1.11 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $1.22 Million - $1.59 Million	4,302 Added 53775.0%	4,310 $1.22 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $14,763 - $23,638	-57 Reduced 87.69%	8 $2,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $1,700 - $1,992	7 Added 12.07%	65 $18,000
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $352,263 - $530,244	-1,491 Reduced 96.26%	58 $14,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $1.56 Million - $1.8 Million	-5,895 Reduced 79.19%	1,549 $439,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $12.4 Million - $16.4 Million	-47,765 Reduced 86.52%	7,444 $1.99 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $1.81 Million - $2.29 Million	-6,720 Reduced 10.85%	55,209 $17.5 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $6.8 Million - $9.4 Million	-30,907 Reduced 33.29%	61,929 $18.4 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $339,858 - $381,184	1,563 Added 1.71%	92,836 $21.6 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $49.2 Million - $54.3 Million	-224,567 Reduced 71.1%	91,273 $21.3 Million
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $57.8 Million - $90.5 Million	-266,887 Reduced 45.8%	315,840 $74.7 Million
Q4 2018 Aug 28, 2019	BUY	$278.5 - $352.75 $20 Million - $25.3 Million	71,804 Added 14.05%	582,727 $175 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $21.8 Million - $27.7 Million	-78,447 Reduced 13.31%	510,923 $154 Million
Q3 2018 Aug 30, 2019	BUY	$293.51 - $383.83 $21.7 Million - $28.4 Million	73,921 Added 14.34%	589,370 $208 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $50.5 Million - $66.1 Million	-172,177 Reduced 25.04%	515,449 $182 Million
Q2 2018 Aug 30, 2019	BUY	$257.52 - $306.91 $19.4 Million - $23.1 Million	75,315 Added 12.3%	687,626 $200 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $51.7 Million - $61.7 Million	-200,940 Reduced 24.71%	612,311 $178 Million
Q1 2018 Aug 28, 2019	BUY	$260.13 - $367.91 $17.8 Million - $25.2 Million	68,534 Added 9.2%	813,251 $223 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $2.42 Million - $3.42 Million	9,284 Added 1.26%	744,717 $204 Million
Q4 2017 Aug 28, 2019	BUY	$307.64 - $344.58 $12.5 Million - $14 Million	40,491 Added 5.83%	735,433 $234 Million
Q4 2017 Feb 13, 2018	SELL	$307.64 - $344.58 $26.6 Million - $29.8 Million	-86,546 Reduced 11.07%	694,942 $221 Million
Q3 2017 Aug 19, 2019	BUY	$281.15 - $329.69 $9.68 Million - $11.3 Million	34,418 Added 4.61%	781,488 $245 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $53.4 Million - $62.7 Million	190,093 Added 34.13%	747,070 $234 Million
Q2 2017 Aug 19, 2019	BUY	N/A	167,388 Added 42.97%	556,977 $151 Million
Q1 2017 Aug 13, 2019	BUY	N/A	388,280 Added 29662.34%	389,589 $107 Million
Q4 2016 Jul 30, 2019	SELL	N/A	-210 Reduced 13.82%	1,309 $371,000
Q3 2016 Aug 07, 2019	SELL	N/A	-25,024 Reduced 94.28%	1,519 $475,000
Q2 2016 Jul 29, 2019	SELL	N/A	-6,672 Reduced 20.09%	26,543 $6.42 Million
Q1 2016 Jul 25, 2019	SELL	N/A	-9,278 Reduced 21.83%	33,215 $8.65 Million
Q4 2015 Jul 24, 2019	BUY	N/A	9,948 Added 30.57%	42,493 $13 Million
Q3 2015 Jul 15, 2019	SELL	N/A	-6,919 Reduced 17.53%	32,545 $9.5 Million
Q2 2015 Jul 08, 2019	SELL	N/A	-17,389 Reduced 30.59%	39,464 $15.9 Million
Q4 2014 Aug 29, 2019	BUY	N/A	56,853	56,853 $19.3 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Biogen Inc. Transaction History